Epidemiological map of onchocerciasis in Nyagak-Bondo Focus

Slides:



Advertisements
Similar presentations
Module 2 Eligibility for a TAS TAS Global Programme to Eliminate Lymphatic Filariasis (GPELF) Training in monitoring and epidemiological assessment of.
Advertisements

Training in monitoring and epidemiological assessment of mass drug administration for eliminating lymphatic filariasis Module 1 Background.
Module 6 After the survey TAS Global Programme to Eliminate Lymphatic Filariasis (GPELF) Training in monitoring and epidemiological assessment of mass.
Malaria Elimination in Zanzibar. Introduction Dramatic declines in malaria morbidity and mortality over the last decade (prevalence remained
By Patrick Foote. Is a nematode. Causes Ochocerciasis or “river blindness” Nematode does not cause blindness, but its endosymbiont Wolbacia pipientis.
Onchocerciasis (River Blindness). River Blindness, a parasitic disease, is the second leading infectious cause of blindness.
Module 3 Evaluation unit
Main conclusions and recommendations Technical Advisory Group and Annual Meeting on Buruli ulcer Geneva, Switzerland 13 – 17 March 2006.
The Cape Verde experience with rubella outbreak & lessons from introducing rubella vaccines MoH Cape Verde ARCI meeting Dar es Salaam, Tanzania Dec 2012.
Presented by Ijedinma Abanobi, M.P.H Student PUBH Environmental Health Walden University Instructor: Dr. Patrick Tschida Fall, 2011.
Katherine Swift Ph.D Student Walden University PUBH Instructor Dr. Raymond Thron Spring, 2009.
3 July  Background Information  Objectives  Methodology  Results  Discussion  Conclusion  Recommendation Presentation Outline.
Eliminating Lymphatic Filariasis in the Americas A Winnable Battle Center for Global Health Division of Parasitic Diseases and Malaria.
2 Eye Diseases I Hope You Never Experience (and 1 You Probably Will)
1 EL RAHAD FIELD RESEARCH CENTRE - CHALLENGING HEALTH PROBLEMS - WESTERN SUDAN SULAIMAN, S. M. M.Sc. (LSHTM), Ph.D. ( U. of Khartoum) Research Professor.
By Macben Chibuife. 1IntroductionHypothesis Specific Aim 2CausesSignificance 3DesignInnovation.
Post-MDA surveillance ( including xeno-monitoring) Krishnamoorthy K. Vector Control Research Centre Pondicherry India.
Household-wide ivermectin treatment for head lice in an impoverished community: randomized observer- blinded controlled trial Daniel Pilger,Jorg Heukelbach,Adak.
Module 7 Verification of elmination TAS Global Programme to Eliminate Lymphatic Filariasis (GPELF) Training in monitoring and epidemiological assessment.
Omondi Robert Sadia University of Nairobi
Onchocerciasis (River Blindness)
Abstract ID: 395 Author Name: Araya Sripairoj Presenter Name: Araya Sripairoj Authors: Sripairoj A, Liamputtong P, Harvey K.
Larval Source Management in Africa: Case Studies Charles M. Mbogo Kenya Medical Research Institute, Centre for Geographic Medicine Research, Kilifi.
Indicators in Malaria Program Phases By Bayo S Fatunmbi [Technical Officer, Monitoring & Evaluation] ERAR-GMS, WHO Cambodia.
Entomological Surveillance Working Group (ESWG) Establishing ‘Best Practices’ for Entomological Surveillance: Part 1: Data Management/ Reporting Problem.
Made by John Kiepke, Kyle Murphy, and Chase Wright.
Prevention of Mother-to-Child Transmission of HIV: Scale-up of Critical Services in Uganda (District- based Approach) Edward Bitarakwate, MD, MPH Technical.
Are we there yet? Spatial-temporal trend of mother to child HIV transmission in western Kenya, Anthony Waruru, Thomas Achia, Hellen Muttai, Lucy.
Analytical Observational Studies
World Health Organization
Situational Analysis and Needs Assessment: CLIMATE CHANGE AND HEALTH IN ETHIOPIA Establishing a GEOHealth Hub for East Africa School of Public Health,
Moses Katabarwa1 and Frank O. Richards1
Fieldwork research conducted in Lindi and Mtwara Districts (Fig. 1)
Dr. Upendo John Mwingira NTD programme manager
Umm Al-Qura University
TB- HIV Collaborative activities in Romania- may 2006 status
River blindness in Africa
Onchocerciasis Disease (River Blindness)
DATA DISAGGREGATION IN PROJECTS
Pharmacy and Therapeutics Committees in Thai Hospitals under Health Reform Sripairoj A, Liamputtong P, Harvey K La Trobe University, Australia.
ASTMH 63rd Annual Meeting November 2-6, New Orleans, USA
Copyright © 2017 American Academy of Pediatrics.
Seasonal variations of Onchocerciasis vector Simulium damnosum sensu lato in AbuHamed and Galabat foci in Sudan Arwa Elaagip B. Sc. (honors), M. Sc., PhD.
ADEIGA.A, AWODERU O.A,FANEYE.A, AKINTUNDE, GB, ONYEWUCHE.J.
Introduction to CAUTI and CLABSI Initiatives
APPMG December 17, 2008 Presented by Dr. John P. Rumunu (MPH, MB.BS)
Where we could be by 2015 and how to get there
HIV Quality Improvement (QI) and the Treatment Cascade: How QI has Impacted Reach, Recruitment, Testing, Treatment, and Retention Efforts in Thailand?
23 November, 2018 Update on measles & rubella surveillance in the WHO African Region – progress and challenges Dr Richard Luce WHO/IST-Central 5th African.
Evidence-based vector control
Insight to Future Sight Investing in the Future
Jepkoech Kottutt1, Emilia D. Rivadeneira2, Susan Hrapcak2
Onchocerca volvulus David Meyer.
Onchocerciasis: (On-kough-sir-KY-A-sis) “River blindness”
Resource 1. Evaluation Planning Template
Updates on IPC Acute Malnutrition GNC Meeting, Amman, Oct 2018
Onchocerciasis (River Blindness)
Non-Adherence to Community Directed Treatment with Ivermectin for Onchocerciasis Elimination in the Tain District of Ghana Jeffrey Gabriel Sumboh¹.
ONCHOCERCA VOLVULUS Trisha Patel.
Mectizan Donation for IDA countries
Maintaining Elimination in an Environment of Persistent Importation
Sample Sizes for IE Power Calculations.
RTI International Daniel A. Cohn Sr Technical Advisor
National Immunization Conference-April 22, 2010
National Immunization Conference
Stakeholder engagement and research utilization: Insights from Namibia
March 8, 2006 New ACIP Hepatitis B Recommendations
Presentation transcript:

Epidemiological map of onchocerciasis in Nyagak-Bondo Focus ONCHOCERCIASIS TRANSMISSION CONTINUES IN NYAGAK-BONDO FOCUS OF NORTHWESTERN UGANDA AFTER 18 YEARS OF ANNUAL DISTRIBUTION OF IVERMECTIN Moses N Katabarwa1, Tom Lakwo2, Peace Habomugisha3, Stella Agunyu3, Edson Byamukama3, Ephraim Tukesiga4, Dickson Unoba 5, Patrick Dramuke6 Frank Walsh7 and Frank Richards1 1 The Carter Center, Atlanta, USA, 2Ministry of Health, Uganda, 3The Carter Center, Uganda, 4Kabarole District Health service, 5Nebbi District Health service, 6Zombo District Health service, and 7United Kingdom #611 Abstract No: 2428 Background Results Conclusions and Recommendations Follow up mf rates in adults (2011) range is 3.4%-40%, and 4/7 communities still above 20%, a threshold for mass treatment after 18 yrs of a single annual dose of ivermectin. Follow up mf rates in children (2011) range is 0-36.8%, and 6/7 communities with at least 8% implying continuing transmission. 63.6% (2333) crabs were infested with larvae stages of S.neavei. Transmission is continuing, and mass treatment should continue. Uganda Onchocerciasis Elimination Expert Advisory Committee (UOEEAC) recommended launching of twice yearly treatment with ivermectin. Nyagak-Bondo focus covers Zombo District and parts of Nebbi and Arua districts of West Nile Region. The focus borders DRC, and River Nyagak, R. Ora and Agoi are main systems. The vector is S.neavei breeding in the middle reaches of the above systems. Annual mass treatment commenced in 1993. As the policy in Africa begin to shift from control to elimination, impact assessment results of North region becomes key in the debate for selection of effective policies and tools against onchocerciasis. Eligible Population covered in Nyagak-Bondo Focus from 1993-2010 Epidemiological map of onchocerciasis in Nyagak-Bondo Focus Katabarwa M, Eyamba A, Habomugisha P, Lakwo T, Ekobo S, Kamgno J, Kuete T, Ndyomugyenyi R, Onapa A, Salifou M, Ntep M, Richards FO (2008). After a decade of annual dose mass ivermectin treatment in Cameroon and Uganda, onchocerciasis transmission continues. Trop Med Int Health. 13(9):1196-203. Diawara L, Traoré MO, Badji A, Bissan Y, Doumbia K, Goita SF, Konaté L, Mounkoro K, Sarr MD, Seck AF, Toé L, Tourée S, Remme (2009). Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal. PLoS Negl Trop Dis, 3(7):e497. Katabarwa MN, Eyamba A, Chouaibou M, Enyong P, Kuété T, Yaya S, Yougouda A, Baldiagaï J, Madi K, Andze GO, Richards F (2010). Does onchocerciasis transmission take place in hypoendemic areas? a study from the North Region of Cameroon. Trop Med Int Health. 15(5):645-52. Katabarwa M N, Eyamba A, Nwane P, Enyong P, Yaya, Baldiagaï J, Madi K, Yougouda A, Andze G.O, and Richards F (2011). Seventeen years of annual distribution of ivermectin has not interrupted onchocerciasis transmission in North Region, Cameroon. Am. J. Trop. Med. Hyg., 85(6), 1041–1049 References Adults microfilariae (mf) prevalence Objectives of the study to assess the impact of a single dose of ivermectin just before mass treatment of 2011,on the prevalence of microfilaria (mf) and nodule prevalence in adults and children. to assess the level of crab infestation with larval stages of S.neavei in the follow up study. to assess the infection rates in S.neavei. to determine whether an annual dose of ivermectin has eliminated transmission of onchocerciasis after 18 years. Microfilariae (mf) prevalence – Children < 10 years old Examining a crab A Crab Trap Methods The present study followed up ( in 2011) the baseline surveys of 1993 on parasitological, and added in the follow up study, entomological surveys (i.e crab infestation and infective rates). Consent was obtained: Only persons who approved and signed consent forms were examined (parents approved for children). The study was approved by Emory IRB as “non-research, and classified as routine program monitoring. Crab infestation with larval stages of S. neavei Acknowledgements Parasitological The skin was cleaned with alcohol, and sterilized needle, and a new surgical blade was used per individual in order to avoid disease transmission. Skin snip in normal saline solution was observed under microscope after 12-24 hrs. Entomological Three Simulium vector fly collections points were established in April 2011. The black flies collected were preserved for PCR analysis. Crabs were captured and analysed for larval stages of S.neavei Ministry of health and district health services personnel are acknowledged for ensuring annually distribution of ivermectin since 1993, and conducting necessary surveys in affected communities. Without the support of these communities, good treatment coverages and results from the surveys would not have been possible. Merck & Co/Mectizan Donation program are acknowledged for ensuring availability of free ivermectin annually. Also acknowledged are CBM/Kuluva Hospital that provided financial assistance to Arua District, while the Lions Clubs International Foundation/Uganda Lions Clubs, African Programme For Onchocerciasis Control (APOC) provided financial assistance. The River Blindness Foundation, Mr. John Moores and The Carter center are also acknowledged for providing financial, managerial, and technical assistance. S. neavei collection Monthly S. neavei collection in Nyagak-Bondo focus began in April, 2011 and will continue for at least 12 months. Analysis will be done with PCR.